Venture Capital

Tohoku University Venture Partners Co., Ltd.

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage

Geographical Focus
Japan

Industries Focus

  • Technology
  • Healthcare
  • Energy
  • Consumer Goods
  • Agriculture
  • Artificial Intelligence
  • Food and Beverage
  • Pharmaceuticals
  • Medical Devices
  • Semiconductors
  • Robotics
  • Biotechnology
  • Materials Science
  • Environmental Services
  • Advanced Manufacturing

Investment Size:
1,000,000 to 10,000,000 USD

Investor Details Founded: 2015

Tohoku University Venture Partners Co., Ltd. (THVP) is a venture capital firm established in 2015, fully funded by Tohoku University under the Public-Private Sector Innovation Program supported by Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT). THVP's primary mission is to support the commercialization of innovative technologies developed within the university by providing funding and strategic guidance to startups and ventures. This initiative aims to bridge the gap between academic research and practical applications, fostering the growth of new businesses that contribute to societal advancement.

The firm employs a comprehensive investment strategy that encompasses various stages of startup development, including seed, early, and growth stages. THVP's portfolio spans a diverse array of industries, reflecting the broad spectrum of research conducted at Tohoku University. By investing in sectors such as technology, healthcare, biotechnology, and environmental services, THVP seeks to promote sustainable innovation and address global challenges. The firm's approach is characterized by active involvement in its portfolio companies, offering not only financial support but also access to the university's extensive research resources and networks.

THVP's track record includes the establishment of multiple funds, such as the THVP-2 Fund launched in October 2020, which focuses on investments within the Tohoku region. The firm's leadership, under President Tetsuro Higuchi, brings extensive experience from previous roles in venture capital and corporate management. This expertise enables THVP to effectively identify promising startups and provide them with the necessary support to succeed in competitive markets. Through its strategic investments and collaborative efforts, THVP plays a pivotal role in translating academic research into real-world innovations that benefit society at large.

Requirements
  • Startups based on Tohoku University's research achievements
  • Innovative technologies with commercialization potential
  • Alignment with societal advancement goals
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Abliva AB
  • Aptose Biosciences Inc.
  • CureApp, Inc.
  • Fujitsu Laboratories Ltd.
  • GenoMed, Inc.
  • Haplogen AB
  • InnoJapan Co., Ltd.
  • Kirin Holdings Company, Limited
  • Mitsubishi Chemical Corporation
  • Nihon Medi-Physics Co., Ltd.
  • Ono Pharmaceutical Co., Ltd.
  • PeptiDream Inc.
  • Sosei Group Corporation
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Takeda Pharmaceutical Company Limited
Claim this Investor

Are you an official representative of Tohoku University Venture Partners Co., Ltd.?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim